Computer Aided Screening for Tuberculosis in Low Resource Environments
Conditions: Tuberculosis Infection; HIV Infections Interventions: Diagnostic Test: CAD4TB; Diagnostic Test: FujiLAM Sponsors: London School of Hygiene and Tropical Medicine; Liverpool School of Tropical Medicine; University of Malawi College of Medicine; Malawi-Liverpool-Wellcome Trust Clinical Research Programme Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2020 Category: Research Source Type: clinical trials
Computer Aided Screening for Tuberculosis in Low Resource Environments
Conditions: Tuberculosis Infection; HIV Infections Interventions: Diagnostic Test: CAD4TB; Diagnostic Test: FujiLAM Sponsors: London School of Hygiene and Tropical Medicine; Liverpool School of Tropical Medicine; University of Malawi College of Medicine; Malawi-Liverpool-Wellcome Trust Clinical Research Programme Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2020 Category: Research Source Type: clinical trials
Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients
Condition: Tuberculosis Intervention: Drug: BCG-PPD Sponsors: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.; Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital); Beijing Kangterike Statistical Technology Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 4, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition: Latent Tuberculosis Interventions: Other: Strategy 2: Symptom screen, Genexpert and TST; Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
